Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review
Study context
- Population
- Patients with COVID-19-related acute respiratory distress syndrome (ARDS), incl. pregnant women, pediatric patients and lung transplant candidates
Main finding
As reported in the abstract
- Veno-venous (VV) extracorporeal membrane oxygenation (ECMO) the default choice for refractory respiratory failure; Venoarterial (VA) ECMO or Oxy-RVAD considered with concomitant severe right ventricular dysfunction
- ECMO also used in pregnant women, pediatric patients with severe COVID-19, and as a bridge to lung transplantation in persistent, seemingly irreversible respiratory failure
- Mortality of COVID-19-related ARDS variously reassessed during the pandemic
Original publication
Extracorporeal membrane oxygenation for COVID-19-related acute respiratory distress syndrome: a narrative review. J Intensive Care. Published 8 February 2023. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →